IRAK4-IN-21
Product Specifications
CAS Number
2170694-04-7
Target
Others, IRAK
Related Pathways
NF-κB, Others, Immunology/Inflammation
Bioactivity
IRAK4-IN-21 is a selective, orally active, potent IRAK4 inhibitor that acts on IRAK4 (IC50: 5 nM) and TAK1 (IC50: 56 nM) . IRAK4-IN-21 exhibits potent inhibition of IL-23 production with an IC50 value of 0.17 μM. can be used to study autoimmune diseases, such as plaque psoriasis and psoriatic arthritis.
Smiles
N([C@@H]1[C@@]2(C[C@]([C@@H]1C(N)=O)(C=C2)[H])[H])C=3C(=CN=C(NC4=CC(C(=O)N5CCCC5)=CC=C4)N3)C=6C=C(F)C=NC6
Molecular Formula
C28H28FN7O2
Molecular Weight
513.57
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HY-W033559 1 Each
Carbonylhydrido (tetrahydroborato) [bis (2-diphenylphosphinoethyl) aMino]ruthenium (II)
Sign In for Pricing
View Details LS005794-20ug 20 µg
SAP1 (PTPRH) (NM_002842) Human Over-expression Lysate
Sign In for Pricing
View Details 128740-ML650 100 µL
KCNG3 (Potassium Voltage-gated Channel Subfamily G Member 3, Voltage-gated Potassium Channel Subunit Kv10.1, Voltage-gated Potassium Channel Subunit Kv6.3) (MaxLight 650)
Sign In for Pricing
View Details